• Assessing the Impact of a Designated Pharmacist Intervention on Drug Treatment Costs and Technical Efficiency in the Hemato-Oncology Outpatient Clinic [Editor's Choice]

    Nov 1, 2024, 00:00

  • Cost-effectiveness of the Recombinant Zoster Vaccine Among People Living with Human Immunodeficiency Virus in Japan [VHRI Volume 44, November 2024, 101025]

    Nov 1, 2024, 00:00

  • Analysis of Factors Influencing Hospitalization Expenses of Patients With Gastric Cancer in Shanghai, 2014-2021: Based on Grey Relational Analysis and Structural Equation Modeling [Editor's Choice]

    Nov 1, 2024, 00:00

  • Health-Related Quality of Life in Chronic Pain Treated With Tapentadol Versus Oxycodone/Naloxone and Its Determinants: A Real-World, Single-Center Retrospective Cohort Study in Spain

    Nov 1, 2024, 00:00

  • Custo-Efetividade de Diferentes Tratamentos Minimamente Invasivos Para Disfunção Temporomandibular de Origem Articular sob a Perspectiva do Sistema Público de Saúde Brasileiro

    Nov 1, 2024, 00:00

  • Patient Experience of Herpes Zoster Disease in Argentina: Validation of a Health-Related Quality of Life Conceptual Model

    Nov 1, 2024, 00:00

  • Changes in Health Spending During the COVID-19 Pandemic by Expenditure Type and Household Profiles in Mexican Households [Editor's Choice]

    Nov 1, 2024, 00:00

  • Psychometric Measurements of the Adherence to Refills and Medication Scales Among Patients With HIV/AIDS in Indonesia

    Nov 1, 2024, 00:00

  • Societal Preferences in Health Technology Assessments for Rare Diseases and Orphan Drugs: A Systematic Literature Review of New Analytic Approaches

    Nov 1, 2024, 00:00

  • Cost-Effectiveness of Dolutegravir Compared With Efavirenz for Prevention of Perinatal Transmission in Women Presenting With HIV in Late Pregnancy in Uganda

    Nov 1, 2024, 00:00

  • Evaluation of the Concept of Value-Based Healthcare Applied to an Integrated Palliative Care Program in Colombia [Editor's Choice]

    Sep 1, 2024, 00:00

  • Lenalidomide or Thalidomide for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma? An Overview of Systematic Reviews

    Sep 1, 2024, 00:00

  • Cost-Effectiveness of Increasing Access to Colorectal Cancer Diagnosis: Analysis From Thailand

    Sep 1, 2024, 00:00

  • Challenges and Reflections on Pandemic Disinformation: The Case of Hydroxychloroquine and the Implications for Global Public Health

    Sep 1, 2024, 00:00

  • Editorial Board

    Sep 1, 2024, 00:00

  • Hospital Healthcare Resource Utilization and Associated Hospital Costs of Patients With Lupus Nephritis in China: A National Administrative Claim Database Study

    Sep 1, 2024, 00:00

  • Consensus-Based Recommendations for the Implementation of Health Technology Assessment in the United Arab Emirates

    Sep 1, 2024, 00:00

  • Societal Preferences for Subsidizing Treatments Targeting Patients With Advanced Illness: A Discrete Choice Experiment [Editor's Choice]

    Sep 1, 2024, 00:00

  • Incremental Healthcare Costs of Diabetes Mellitus in a Middle-Income Country Using Administrative Healthcare Data [Editor's Choice]

    Sep 1, 2024, 00:00

  • Long-Term Cost-Effectiveness of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Adults With Type 1 Diabetes in Iran [Editor's Choice]

    Sep 1, 2024, 00:00

  • Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database

    Sep 1, 2024, 00:00

  • Microcosting Analysis of Advanced Ovarian Cancer: Real-World Evidence From the Perspective of a Reference Public Brazilian Hospital

    Sep 1, 2024, 00:00

  • Patient Preferences for Out-of-Hospital Cardiac Arrest Care in South Africa: A Discrete Choice Experiment

    Sep 1, 2024, 00:00

  • Simplified Chronic Hepatitis B Antiviral Initiation Criteria in Thailand: An Economic Evaluation

    Sep 1, 2024, 00:00

  • Cost-Utility Analysis of Maintenance Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Non–Small Cell Lung Cancer in Jordan

    Sep 1, 2024, 00:00

  • The Impact of COVID-19 on Healthcare Utilization in Turkey

    Sep 1, 2024, 00:00

  • The Impact of Generic Entry of Pharmaceuticals in Australia [Editor's Choice]

    Sep 1, 2024, 00:00

  • Table of Contents

    Aug 27, 2024, 14:16

  • A Microcost Analysis of the Use of Personal Protective Equipment During and Before the COVID-19 Pandemic From a Hospital Perspective

    Jul 1, 2024, 00:00

  • Mortalidad, Secuelas Clínicas y Calidad de Vida Luego del Alta de Unidades de Cuidados Intensivos en Pacientes con COVID-19: Estudio Multicéntrico Descriptivo en Argentina

    Jul 1, 2024, 00:00

  • The Process of Listing Prostheses and Medical Devices in Thailand’s Universal Health Coverage [Editor's Choice]

    Jul 1, 2024, 00:00

  • Tiered Pricing and Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature

    Jul 1, 2024, 00:00

  • Cost-Effectiveness Analysis of Pharmacological Treatment for Adult Kidney Transplant Recipients in Colombia [Editor's Choice]

    Jul 1, 2024, 00:00

  • Electronic Decision-Making Tool for Smoking Cessation (Pare de Fumar Conosco) Versus Standard of Care: A Cost-Effectiveness Analysis

    Jul 1, 2024, 00:00

  • Table of Contents

    Jul 1, 2024, 00:00

  • Quality of Life in Transfusion-Dependent Thalassemia Patients in Greece Before and During the COVID-19 Pandemic

    Jul 1, 2024, 00:00

  • Cost-Effectiveness of Technologies for the Treatment of Spinal Muscular Atrophy: A Systematic Review of Economic Studies [Editor's Choice]

    Jul 1, 2024, 00:00

  • Strategic Approaches to Reducing the Burden of Atopic Dermatitis in the Middle East and Africa Region

    Jul 1, 2024, 00:00

  • Estimating the SF-6Dv1 Value Set for a Population-Based Sample in Lebanon [Editor's Choice]

    Jul 1, 2024, 00:00

  • Cost-Effectiveness of Ibrutinib for Chronic Lymphocytic Leukemia Treatment in India: Is Evidence Really at Crossroads?

    Jul 1, 2024, 00:00

  • Partial-Cost Analysis and Economic Impact of Ambulatory Coronary Angioplasty in a Private Hospital in the Caribbean

    Jul 1, 2024, 00:00

  • Editorial Board

    Jul 1, 2024, 00:00

  • Cost-Effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients With Metastatic Prostate Cancer: A Societal Perspective

    Jul 1, 2024, 00:00

  • Cost-Effectiveness Analysis of Implant-Supported Single Crown and Tooth-Supported Fixed Dental Prostheses in Türkiye

    Jul 1, 2024, 00:00

  • Examining the Impact of the Current Reimbursement Regulation on Patient Access to Innovative Medical Devices in Taiwan: Insights From 8 Years’ Reimbursement Data [Editor's Choice]

    Jul 1, 2024, 00:00

  • Table of Contents

    May 7, 2024, 17:27

  • The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand [Editor's Choice]

    May 1, 2024, 00:00

  • Cost-Effectiveness Analysis Comparing QuantiFERON-TB Gold Plus Test and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Immunocompetent Subjects in Colombia

    May 1, 2024, 00:00

  • Service Utilization Patterns and Direct Medical Costs of Hospitalization in Patients With Renal Failure Before and After Initiating Home Peritoneal Dialysis

    May 1, 2024, 00:00

  • Financial Toxicity Experiences of Patients With Cancer in Indonesia: An Interpretive Phenomenological Analysis

    May 1, 2024, 00:00

  • Impact of Lung Cancer on Health-Related Quality of Life, Financial Toxicity, and Household Economics in Patients From the Public and the Private Healthcare Sector in Argentina [Editor's Choice]

    May 1, 2024, 00:00

  • Editorial Board

    May 1, 2024, 00:00

  • Estimating the Costs of End-of-Life Care in Patients With Advanced Cancer From the Perspective of an Insurance Organization: A Cross-Sectional Study in Iran

    May 1, 2024, 00:00

  • The Short-Term Cost-Effectiveness of a Fixed-Ratio Combination of Insulin Degludec and Aspart: A Cost of Control Analysis in Australia and India

    May 1, 2024, 00:00

  • Portuguese Global Medicines Access Index 2021: An Indicator to Measure Access to Hospital Medicines

    May 1, 2024, 00:00

  • Economic Evaluation of Neoadjuvant Versus Adjuvant Chemotherapy in Cancer Treatment: A Systematic Review and Meta-Analysis

    May 1, 2024, 00:00

  • Psychometric Properties of the Persian Dizziness Handicap Inventory – Screening Version

    May 1, 2024, 00:00

  • Peripherally Inserted Central Catheter Versus Centrally Inserted Central Catheter for In-Hospital Infusion Therapy: A Cost-Effectiveness Analysis

    May 1, 2024, 00:00

  • Assessment of Extent and Quality of Pharmacoeconomic Studies in India Using Quality of Health Economic Studies Score: A Targeted Literature Review

    May 1, 2024, 00:00

  • The Shortfalls of Mental Health Compartment Models: A Call to Improve Mental Health Investment Cases in Developing Countries [Editor's Choice]

    May 1, 2024, 00:00

  • A Step Toward the Development of the First National Multi-Criteria Decision Analysis Framework to Support Healthcare Decision Making in Saudi Arabia [Editor's Choice]

    May 1, 2024, 00:00

  • Analysis of Health-Related Quality of Life and Incurred Costs Among Human Immunodeficiency Virus, Tuberculosis, and Tuberculosis/HIV Coinfected Outpatients in Indonesia

    May 1, 2024, 00:00

  • Quality of Life of Patients With Cancer at the Beni Mellal Oncology Center

    May 1, 2024, 00:00

  • Association of Healthcare Fragmentation and the Survival of Patients With Colorectal Cancer in Colombia [Editor's Choice]

    May 1, 2024, 00:00

  • The Economic Burden of Biological Drugs in Rheumatoid Arthritis Treatment [Editor's Choice]

    Mar 1, 2024, 00:00

  • Evolving Trends and Economic Burden of Benzodiazepine Use: Insights From a 10-Year Predictive Model

    Mar 1, 2024, 00:00

  • Multivariate Relationships Between Health Outcomes and Health System Performance Indicators: An Integrated Factor Analysis With Canonical Correlations [Editor's Choice]

    Mar 1, 2024, 00:00

  • Cost-Effectiveness of Onasemnogene Abeparvovec Compared With Nusinersen and Risdiplam in Patients With Spinal Muscular Atrophy Type 1 in Brazil

    Mar 1, 2024, 00:00

  • Determining the Willingness to Pay for Innovative Oncology Medicines in Malaysia [Editor's Choice]

    Mar 1, 2024, 00:00

  • Exploring the Evolution of Statin Pricing in Australia: Observations of Price Disclosure Effects on Pharmaceutical Benefits Scheme Expenditure

    Mar 1, 2024, 00:00

  • Costs of Receiving Developmental Services for Children With Global Developmental Delay at Siriraj Hospital in Bangkok, Thailand

    Mar 1, 2024, 00:00

  • Cost-Utility Analysis of Continuous Positive Airway Pressure Therapy Compared With Usual Care for Obstructive Sleep Apnea in the Public Health System in Brazil

    Mar 1, 2024, 00:00

  • Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma in Japan

    Mar 1, 2024, 00:00

  • The Urban-Rural Difference in Child Mental Health in Vietnam: The Continuing Impacts of the COVID-19 Pandemic on Health

    Mar 1, 2024, 00:00

  • Editorial Board

    Mar 1, 2024, 00:00

  • Automated Peritoneal Dialysis With Remote Patient Monitoring: Clinical Effects and Economic Consequences for Poland

    Mar 1, 2024, 00:00

  • Economic Burden of Alzheimer’s Disease: A Systematic Review

    Mar 1, 2024, 00:00

  • Cost-Utility Model of Nirmatrelvir/Ritonavir in Brazil: Analysis of a Vaccinated Population [Editor's Choice]

    Mar 1, 2024, 00:00

  • A Vulnerability Index for Mitigation and Prevention of Diabetes Growth in India: A Disaggregated Analysis [Editor's Choice]

    Mar 1, 2024, 00:00

  • Comparative Analysis of the Healthcare Delivery System in China and Nigeria: A Review

    Mar 1, 2024, 00:00

  • Table of Contents

    Feb 26, 2024, 08:36

  • Copyright/Subscription

    Jan 12, 2024, 10:29

  • Revision of Malawi’s Health Benefits Package: A Critical Analysis of Policy Formulation and Implementation [Editor's Choice]

    Jan 1, 2024, 00:00

  • Looking to the Future: A Vision for Value in Health Regional Issues

    Jan 1, 2024, 00:00

  • Study of the Direct Costs of Asthma at a Healthcare Service Provider in Bogotá, Colombia

    Jan 1, 2024, 00:00

  • Editorial Board

    Jan 1, 2024, 00:00

  • Estimation of Societal Values of Health States Preferences at the National Level for Low- and Middle-Income Countries [Editor's Choice]

    Jan 1, 2024, 00:00

  • Breast Cancer Screening in Georgia: Choosing the Most Optimal and Cost-Effective Strategy

    Jan 1, 2024, 00:00

  • Research-to-Policy Partnerships for Evidence-Informed Resource Allocation in Health Systems in Africa: An Example Using the Thanzi Programme

    Jan 1, 2024, 00:00

  • Forging Partnership Between Health Economics Researchers and Policy Makers: Better Methods, Better Policy, Better Health

    Jan 1, 2024, 00:00

  • Central America and the Dominican Republic at Crossroads: The Importance of Regional Cooperation and Health Economic Research to Address Current Health Challenges

    Jan 1, 2024, 00:00

  • The Checklist for Standard Methodological Requirements and Reporting of Economic Evaluation of Medicines in Slovakia

    Jan 1, 2024, 00:00

  • Cost-Effectiveness of Comprehensive Genomic Profiling in Patients With Non–Small Cell Lung Cancer for the Colombian Health System [Editor's Choice]

    Jan 1, 2024, 00:00

  • Decision-Utility Analysis of Empiric Treatment Versus Test and Treat Strategies for Helicobacter pylori in Patients With Duodenal Ulcer

    Jan 1, 2024, 00:00

  • Health System Financing and Resource Allocation in Humanitarian Settings: Toward a Collaborative Policy Research Agenda in the Eastern Mediterranean Region

    Jan 1, 2024, 00:00

  • Scoping Review of Health Economics Research on Refugee Health in Sub-Saharan Africa

    Jan 1, 2024, 00:00

  • Demands for Intersectoral Actions to Meet Health Challenges in East and Southern Africa and Methods for Their Evaluation

    Jan 1, 2024, 00:00

  • Economical Evaluation of Prostate Cancer Treatment Using Intensity-Modulated Radiation Therapy, 3-Dimensional Conformal Radiation Therapy and Radical Prostatectomy: A Systematic Review

    Jan 1, 2024, 00:00

  • Table of Contents

    Jan 1, 2024, 00:00

  • Adapting Economic Evaluation Methods to Shifting Global Health Priorities: Assessing the Value of Health System Inputs [Editor's Choice]

    Jan 1, 2024, 00:00

  • Choosing the Best Instrument for Measuring Health Spillover Effect in Caregivers of Patients With Multiple Sclerosis [Editor's Choice]

    Jan 1, 2024, 00:00

  • Copyright/Subscription

    Nov 13, 2023, 10:52

  • Trajectories of Cancer Care in Latin America: A Scope Review

    Nov 1, 2023, 00:00

  • Willingness to Pay for Colorectal Cancer Screening in Vietnam: Policy Implications From a Contingent Valuation Survey [Editor's Choice]

    Nov 1, 2023, 00:00

  • Integrating Noncancer Chronic Pain to Multimorbidity: A Real Practice Challenge in Chile

    Nov 1, 2023, 00:00

  • Cost-Effectiveness of Ibrutinib as First-line Treatment for Older Patients With Chronic Lymphocytic Leukemia in Iran

    Nov 1, 2023, 00:00

  • Editorial Board

    Nov 1, 2023, 00:00

  • Cost-Effectiveness of Hospice Palliative Care for Patients With Cancer and Family Caregivers: A Multicenter Study in Kazakhstan

    Nov 1, 2023, 00:00

  • The Relationship Between the Health Transformation Program and Health Expenditures: Evidence From an Autoregressive Distributed Lag Testing Approach

    Nov 1, 2023, 00:00

  • Cost-Effectiveness of Osteoporosis Opportunistic Screening Using Computed Tomography in China [Editor's Choice]

    Nov 1, 2023, 00:00

  • Table of Contents

    Nov 1, 2023, 00:00

  • The Cost-Effectiveness of Pertuzumab for the Treatment of Metastatic HER2+ Breast Cancer in Czechia: A Semi-Markov Model Using Cost States

    Nov 1, 2023, 00:00

  • Cost-Effectiveness of Glucose-Lowering Therapies as Add-on to Standard Care for People With Type 2 Diabetes in Malaysia [Editor's Choice]

    Nov 1, 2023, 00:00

  • Evaluation of a Transitional Care Strategy Implemented in Adults With High-Risk and Multimorbidity in Chile

    Nov 1, 2023, 00:00

  • Cost-Effectiveness of Tacrolimus Compared With Cyclosporine for Immunosuppression Therapy in Patients Who Underwent Heart Transplant in Colombia

    Nov 1, 2023, 00:00

  • Home Gardening of Yellow Cassava and Orange Maize for the Prevention of Nutritional Blindness in Children: An Economic Evaluation and Value of Information Analysis

    Nov 1, 2023, 00:00

  • Should the Preference-Based Index Set of Values Be Country or Disease Specific? An Analysis Using Data From Women With Symptoms of Overactive Bladder

    Nov 1, 2023, 00:00

  • Critical Analysis of Economic Evaluation of the Childhood Rotavirus Vaccination in Low- and Lower-Middle-Income Countries: A Systematic Review

    Nov 1, 2023, 00:00

  • Early Cost-Utility Analysis of Ataluren and Eteplirsen in the Treatment of Duchenne Muscular Dystrophy in Egypt

    Nov 1, 2023, 00:00

  • Factors Affecting Inequality in the Quality Diets: A Scoping Review

    Sep 1, 2023, 00:00

  • Sensitivity Analysis in Economic Evaluations of Immuno-Oncology Drugs: A Systematic Literature Review

    Sep 1, 2023, 00:00

  • The Triglycerides and Glucose Index: A Cost-Effectiveness Analysis Compared With the Homeostatic Model Assessment for Insulin Resistance

    Sep 1, 2023, 00:00

  • The Budget Impact Analysis of Adopting Direct Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation Patients in Malawi

    Sep 1, 2023, 00:00

  • Healthcare Costs and Utilization for Patients With Systemic Lupus Erythematosus in China: A National Claims Database Study [Editor's Choice]

    Sep 1, 2023, 00:00

  • Real-World Costs and Cost-Effectiveness Analysis of Rabbit-Antithymocyte Globulin Versus Oxymetholone in Acquired Aplastic Anemia in Thailand

    Sep 1, 2023, 00:00

  • Prioritizing Outcome Measures for Value-Based Healthcare: Physicians’ Perspectives in Saudi Arabia

    Sep 1, 2023, 00:00

  • Table of Contents

    Sep 1, 2023, 00:00

  • Editorial Board

    Sep 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Monoclonal Antibodies Associated With Chemotherapy in First-Line Treatment of Metastatic Colorectal Cancer

    Sep 1, 2023, 00:00

  • Instructions for Authors

    Sep 1, 2023, 00:00

  • Burden of COVID-19 in Córdoba, A Department of Colombia: Results of Disability-Adjusted Life-Years

    Sep 1, 2023, 00:00

  • Assessment of Health-Related Quality of Life Using EQ-5D-5L Tool With Indian Tariffs Among Reproductive Age Group Women Living With HIV in India [Editor's Choice]

    Sep 1, 2023, 00:00

  • The Disease Burden and Economic Burden of Cancer in 9 Countries in the Middle East and Africa [Editor's Choice]

    Sep 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Relmacabtagene Autoleucel for Relapsed or Refractory Large B-Cell Lymphoma in China

    Sep 1, 2023, 00:00

  • Exploring the COVID-19 Pandemic’s Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health System [Editor's Choice]

    Sep 1, 2023, 00:00

  • Eficácia E Custo-Utilidade De Intervenções Para O Tratamento Da Enurese Em Crianças E Adolescentes Sob A Perspectiva Do Sistema Único De Saúde Brasileiro

    Sep 1, 2023, 00:00

  • Upfront DPYD Genotype-Guided Treatment for Fluoropyrimidine-Based Chemotherapy in Advanced and Metastatic Colorectal Cancer: A Cost-Effectiveness Analysis

    Sep 1, 2023, 00:00

  • Copyright/Subscription

    Aug 25, 2023, 08:58

  • Cost of Illness in Patients With COVID-19 Admitted in Three Brazilian Public Hospitals [Editor's Choice]

    Jul 1, 2023, 00:00

  • Editorial Board

    Jul 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Rituximab for Chronic Lymphocytic Leukemia Using a Semi-Markovian Model Approach in R

    Jul 1, 2023, 00:00

  • Time From Marketing Authorization to Reimbursement of Medicines in Greece After the Introduction of the Health Technology Assessment Process From July 2018 to April 2022

    Jul 1, 2023, 00:00

  • Real-World Populational-Based Quality of Life and Functional Status After Stroke

    Jul 1, 2023, 00:00

  • Healthcare Resource Utilization in Controlled Versus Uncontrolled Adults Living With Type 1 Diabetes in the South African Public Healthcare Sector [Editor's Choice]

    Jul 1, 2023, 00:00

  • Loss of Health State Utilities Attributable to Obesity [Editor's choice]

    Jul 1, 2023, 00:00

  • Treatment Patterns and Health Resource Utilization in Patients With HR+/ HER2- Locally Advanced or Metastatic Breast Cancer in a Real-World Setting in Taiwan

    Jul 1, 2023, 00:00

  • Table of Contents

    Jul 1, 2023, 00:00

  • Reimbursement Coverage Decision Making for Digital Health Technologies in South Korea: Does It Fit the Value Framework Used in Traditional Medical Technologies? [Editor's Choice]

    Jul 1, 2023, 00:00

  • Does a Standard Cost-Effectiveness Threshold Exist? The Case of Greece [Editor's choice]

    Jul 1, 2023, 00:00

  • Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis

    Jul 1, 2023, 00:00

  • Cost-Utility Analysis Comparing Ocrelizumab Versus Rituximab in the Treatment of Relapsing-Remitting Multiple Sclerosis: The Colombian Perspective

    Jul 1, 2023, 00:00

  • Cost-Effectiveness of Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Hong Kong

    Jul 1, 2023, 00:00

  • Budget Impact Analysis of Utilization of Sacubitril/Valsartan for the Treatment of Heart Failure With Reduced Ejection Fraction in the Philippines

    Jul 1, 2023, 00:00

  • The Use of Economic Evaluation Tools in Essential Health Benefits Package Selection for Universal Health Coverage

    Jul 1, 2023, 00:00

  • Copyright/Subscription

    Jun 14, 2023, 08:36

  • Copyright/Subscription

    May 2, 2023, 08:59

  • The Cost Analysis of Human Papillomavirus Vaccination Program in Indonesia

    May 1, 2023, 00:00

  • The Negative Impact of the New Coronavirus Pandemic on the Trend of Breast Biopsies and Their Direct Costs: Interrupted Time Series Analysis

    May 1, 2023, 00:00

  • Cross-Cultural Adaptation and Validation of the EuroQoL Toddler and Infant Populations Instrument Into Afrikaans for South Africa

    May 1, 2023, 00:00

  • Cost-Utility of Continuous Positive Airway Pressure for Respiratory Distress in Preterm Infants in a Middle-Income Country

    May 1, 2023, 00:00

  • Seemingly Unrelated Regression Analysis of the Cost and Health-Related Quality of Life Outcomes of the REVAMP Randomized Clinical Trial [Editor's Choice]

    May 1, 2023, 00:00

  • Willingness to Pay for Clinical Pharmacy Services Among People With Diabetes in Nigerian Community Pharmacies

    May 1, 2023, 00:00

  • Cost-Effectiveness of Breast Cancer Early Detection Program in Low- and Middle-Income Countries: A Systematic Review [Editor's Choice]

    May 1, 2023, 00:00

  • Editorial Board

    May 1, 2023, 00:00

  • Estimating the Potential Economic Impact of Tissue Valve Replacement for Heart Valve Disease in China: Patient-Level and Population-Level Cost-Benefit Simulation Analyses [Editor's Choice]

    May 1, 2023, 00:00

  • Budget Impact Analysis of Comprehensive Genomic Profiling in Advanced Non–Small Cell Lung Cancer in Taiwan

    May 1, 2023, 00:00

  • Medication Use Questionnaire for Older Adults in Malaysia: Translation, Cultural Adaptation, and Reliability

    May 1, 2023, 00:00

  • Table of Contents

    May 1, 2023, 00:00

  • Exploring the Potential Challenges for Developing Generic Orphan Drugs for Rare Diseases: A Survey of US and European Markets [Editor's Choice]

    May 1, 2023, 00:00

  • Reviewer Acknowledgment 2022

    May 1, 2023, 00:00

  • Impact of Adjuvant FOLFOX on Quality of Life and Peripheral Neuropathy Incidence in Patients With Gastric Cancer: A Prospective Cohort Study

    May 1, 2023, 00:00

  • Cost-Effectiveness of Mepolizumab Add-On in the Treatment of Severe Eosinophilic Asthma in Chile

    May 1, 2023, 00:00

  • An Economic Model to Establish the Costs Associated With Routes to Presentation for Patients With Multiple Myeloma in the United Kingdom

    May 1, 2023, 00:00

  • Copyright/Subscription

    Mar 6, 2023, 08:17

  • Supporting Decisions of the Brazilian Regulatory Agency for Supplementary Healthcare: A Case Study

    Mar 1, 2023, 00:00

  • Shall We Screen Lung Cancer With Low-Dose Computed Tomography? Cost-Effectiveness in Hungary [Editor's Choice]

    Mar 1, 2023, 00:00

  • Editorial Board

    Mar 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Macitentan in Comparison With Bosentan in the Treatment of Pulmonary Arterial Hypertension in Iran

    Mar 1, 2023, 00:00

  • Health State Utility Values of Type 2 Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis [Editor's Choice]

    Mar 1, 2023, 00:00

  • Patient Access to Orphan Drugs Covered by Medical Insurance in China: Real-World Evidence From Patient Survey [Editor's Choice]

    Mar 1, 2023, 00:00

  • Cost of Home-Based Couples Human Immunodeficiency Virus Counseling and Testing and Human Immunodeficiency Virus Self-Testing During Pregnancy and Postpartum in Southwestern Kenya

    Mar 1, 2023, 00:00

  • Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand

    Mar 1, 2023, 00:00

  • Table of Contents

    Mar 1, 2023, 00:00

  • Budget Impact Analysis of Nusinersen for Spinal Muscular Atrophy in China

    Mar 1, 2023, 00:00

  • Economic Impact Analysis of Incorporation of Elecsys sFlt-1/PlGF Ratio Into Routine Practice for the Diagnosis and Follow-Up of Pregnant Women With Suspected Preeclampsia in Argentina

    Mar 1, 2023, 00:00

  • Cost Analysis of Hospitalization for COVID-19 in a Brazilian Public Teaching Hospital

    Mar 1, 2023, 00:00

  • Cost-Effectiveness of Empagliflozin on Top of Standard of Care for Heart Failure With Reduced Ejection Fraction in Singapore

    Mar 1, 2023, 00:00

  • Economic Evaluation of Selected Interleukin Inhibitors Versus Methotrexate for Moderate-to-Severe Plaque Psoriasis From the Philippine Payer Perspective

    Mar 1, 2023, 00:00

  • Economic Evaluation of Immune Tolerance Induction in Children With Severe Hemophilia A and High-Responding Inhibitors: A Cost-Effectiveness Analysis of Prophylaxis With Emicizumab

    Mar 1, 2023, 00:00

  • Patient-Reported Outcome Measures in Key Sub-Saharan African Languages to Promote Diversity: A Scoping Review

    Mar 1, 2023, 00:00

  • The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment: Evidence From a Novel Approach Piloted in South Africa [Editor's Choice]

    Mar 1, 2023, 00:00

  • Current Medical Technology Reimbursement System in Japan [Editor's Choice]

    Mar 1, 2023, 00:00

  • The Social Economic Return of a Positive End-Expiratory Pressure–Based Lung Recruitment Clinical Trial Program in Patients With Acute Respiratory Distress Syndrome

    Jan 1, 2023, 00:00

  • Copyright/Subscription

    Jan 1, 2023, 00:00

  • Cost-Effectiveness of Pediatric Universal Screening for Familial Hypercholesterolemia in Argentina

    Jan 1, 2023, 00:00

  • Estimating Societal Cost of Illness and Patients’ Quality of Life of Duchenne Muscular Dystrophy in Egypt

    Jan 1, 2023, 00:00

  • Editorial Board

    Jan 1, 2023, 00:00

  • Crucial Business Model Elements for Medical Device Startup Companies in Emerging Markets

    Jan 1, 2023, 00:00

  • Costs and Quality of Life in Patients With Systemic Arterial Hypertension in Slovenia

    Jan 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Robotic-Assisted Radical Prostatectomy for Localized Prostate Cancer From the Brazilian Public System Perspective

    Jan 1, 2023, 00:00
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »